Main > > >MYELODYSPLASTIC SYNDROMES. *

Anemia.>TREAT.: Luspatercept-Aamt for
Inj.
EU Approval Date: 2020. 06.26.
USA Approval Date: 2020. 04.03.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 09.20.




TREAT.: Decitabine. (Injection)
USA Approval Date: 2006. 05.02.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 11.21.




TREAT.: Decitabine+Cedazuridine Tablets.
CA/USA Approval Date: 2020. 07.07.
(*) Companies; Patents; TradeMarks &
Web-Site Available on Request.
UpDate: 2020. 09.16.




TREAT.: Lenalidomide Capsules.
USA Approval Date: ?
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 11.08.


>MYELODYSPLASTIC SYNDROMES. *'s products
This section has no products